Tower Research Capital LLC (Trc) Replimune Group, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Replimune Group, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 850 shares of REPL stock, worth $10,871. This represents 0.0% of its overall portfolio holdings.

Number of Shares

850

Previous 27,383 96.9%

Holding current value

$10,871

Previous $246,000 96.34%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$8.09 - $11.23 $214,651 - $297,965	-26,533 Reduced 96.9%	850 $9,000
Q2 2024 Aug 13, 2024	BUY	$5.01 - $9.46 $122,349 - $231,022	24,421 Added 824.48%	27,383 $246,000
Q1 2024 May 15, 2024	SELL	$6.87 - $9.31 $8,553 - $11,590	-1,245 Reduced 29.59%	2,962 $24,000
Q4 2023 Feb 13, 2024	BUY	$6.75 - $16.18 $19,966 - $47,860	2,958 Added 236.83%	4,207 $35,000
Q3 2023 Nov 14, 2023	SELL	$15.96 - $22.18 $118,758 - $165,041	-7,441 Reduced 85.63%	1,249 $21,000
Q2 2023 Aug 14, 2023	BUY	$15.65 - $24.1 $34,383 - $52,947	2,197 Added 33.84%	8,690 $201,000
Q1 2023 May 09, 2023	BUY	$17.48 - $29.09 $67,769 - $112,781	3,877 Added 148.2%	6,493 $115,000
Q4 2022 Feb 10, 2023	SELL	$17.09 - $27.91 $108,743 - $177,591	-6,363 Reduced 70.87%	2,616 $72,000
Q3 2022 Nov 10, 2022	BUY	$15.6 - $21.15 $3,322 - $4,504	213 Added 2.43%	8,979 $155,000
Q2 2022 Aug 15, 2022	SELL	$13.32 - $19.98 $169,550 - $254,325	-12,729 Reduced 59.22%	8,766 $153,000
Q1 2022 May 12, 2022	BUY	$15.24 - $29.75 $252,298 - $492,511	16,555 Added 335.12%	21,495 $365,000
Q4 2021 Feb 14, 2022	BUY	$25.43 - $34.25 $68,254 - $91,927	2,684 Added 118.97%	4,940 $134,000
Q3 2021 Nov 15, 2021	SELL	$28.98 - $39.54 $96,619 - $131,826	-3,334 Reduced 59.64%	2,256 $67,000
Q2 2021 Aug 16, 2021	BUY	$28.5 - $39.37 $99,550 - $137,519	3,493 Added 166.57%	5,590 $215,000
Q1 2021 May 17, 2021	BUY	$30.22 - $45.57 $41,038 - $61,884	1,358 Added 183.76%	2,097 $64,000
Q4 2020 Feb 16, 2021	SELL	$23.5 - $52.65 $409,135 - $916,636	-17,410 Reduced 95.93%	739 $29,000
Q3 2020 Nov 16, 2020	BUY	$18.85 - $27.0 $283,899 - $406,647	15,061 Added 487.73%	18,149 $418,000
Q2 2020 Aug 13, 2020	BUY	$9.76 - $25.95 $15,586 - $41,442	1,597 Added 107.11%	3,088 $77,000
Q1 2020 May 15, 2020	BUY	$8.9 - $19.08 $13,269 - $28,448	1,491 New	1,491 $15,000
Q4 2019 Feb 07, 2020	SELL	$11.61 - $17.21 $6,350 - $9,413	-547 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$10.01 - $16.87 $5,475 - $9,227	547 New	547 $8,000
Q2 2019 Aug 13, 2019	SELL	$12.51 - $17.28 $10,270 - $14,186	-821 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$10.26 - $16.24 $30,041 - $47,550	-2,928 Reduced 78.1%	821 $12,000
Q4 2018 Feb 14, 2019	BUY	$9.97 - $15.57 $17,836 - $27,854	1,789 Added 91.28%	3,749 $37,000
Q3 2018 Nov 13, 2018	BUY	$14.99 - $22.14 $29,380 - $43,394	1,960 New	1,960 $32,000

Others Institutions Holding REPL

# of Institutions

149

Shares Held

68M

Call Options Held

52.3K

Put Options Held

80.3K

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $631M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Replimune Group, Inc. Transaction History